Voloridge Investment Management, LLC Pmv Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.17 - $12.95 $149,233 - $236,544	18,266 Added 7.8%	252,308 $2.2 Million
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $1.79 Million - $2.7 Million	157,440 Added 205.53%	234,042 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $707,036 - $1.72 Million	76,602 New	76,602 $1.09 Million
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $356,209 - $564,517	-23,971 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $608,615 - $920,687	-30,446 Reduced 55.95%	23,971 $554,000
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $1.17 Million - $1.6 Million	43,739 Added 409.62%	54,417 $1.62 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $299,090 - $384,514	10,678 New	10,678 $365,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.